Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board DirectorSeasoned regulatory strategist Darren ...

Johnson & Johnson (J&J) is facing a pivotal legal challenge as it seeks approval for a $10bn settlement plan to resolve allegations that its talc-based baby powder products caused ovarian cancer.The ...

Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby ...

J&J JNJ stock has risen more than 6% in the past month. The reason behind the increase was a strong-than-expected ...

Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...

The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart ...

Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke.

J&J is exploring the sale of Cerenovus, a stroke care business, in a deal potentially worth $1 billion to $1.5 billion. The ...

Now, 340B Health and two safety-net hospitals — UMass Memorial Medical Center (UMMC) in Massachusetts and Genesis HealthCare System in Ohio — want to intervene in J&J’s case to show the ...

NEW YORK (Reuters) - The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal health agencies' payments of medical costs for ...

But no single organization can make such progress alone, which is why J&J actively seeks partnerships with academia, industry, the medical community, patient advocacy groups, professional societie ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US initial public offering as soon as this year, according to people ...